Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q3 FY23 results · Oct–Dec 2022
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,137.39 crore (up 4.1% from Q3 FY22) and net profit of ₹207.47 crore (down 2.2% from Q3 FY22) for Q3 FY23 (Oct–Dec 2022), on a standalone basis.
| Item | Q3 FY23 | Q3 FY22 | YoY | Q2 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,137.39 | 1,092.98 | +4.1% | 1,044.89 | +8.9% |
| Other income | 9.31 | 6.86 | +35.7% | 6.73 | +38.3% |
| Total income | 1,146.70 | 1,099.84 | +4.3% | 1,051.62 | +9.0% |
| Profit before tax | 281.53 | 287.50 | −2.1% | 205.80 | +36.8% |
| Net profit for the period | 207.47 | 212.06 | −2.2% | 154.41 | +34.4% |
| EPS, basic (₹) | 63.91 | 65.33 | −2.2% | 47.57 | +34.3% |
| Net margin (%) | 18.2 | 19.4 | 14.8 |
Standalone
- Filed with BSE
- 01 Feb 2023, 15:20 IST
- Board meeting
- 31 Jan 2023
- Period
- 01 Oct 2022 to 31 Dec 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE